TR201910955T4 - Bakteriyofaj terapisi. - Google Patents
Bakteriyofaj terapisi. Download PDFInfo
- Publication number
- TR201910955T4 TR201910955T4 TR2019/10955T TR201910955T TR201910955T4 TR 201910955 T4 TR201910955 T4 TR 201910955T4 TR 2019/10955 T TR2019/10955 T TR 2019/10955T TR 201910955 T TR201910955 T TR 201910955T TR 201910955 T4 TR201910955 T4 TR 201910955T4
- Authority
- TR
- Turkey
- Prior art keywords
- present
- bacteriophage
- provides
- strain
- adhesive
- Prior art date
Links
- 241001515965 unidentified phage Species 0.000 title abstract 4
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 3
- 241000588724 Escherichia coli Species 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 230000002101 lytic effect Effects 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10171—Demonstrated in vivo effect
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Mevcut buluş, aşağıdakileri içeren bir farmasötik bileşim sağlamaktadır: (i) bir yapışkan-invazif Escherichia coli suşunda bir litik enfeksiyonu üretebilen en az bir bakteriyofaj suşu; ve (ii) inflamatuvar bağırsak hastalığının (IBD) tedavisine yönelik bir farmasötik olarak kabul edilebilir taşıyıcı. Mevcut buluş ayrıca sujenin tedavi edildiği şekilde bir yapışkan-invazif Escherichia coli suşunda bir litik enfeksiyonu üretebilen en az bir bakteriyofaj suşunun, ihtiyaç duyan bir sujeye uygulanmasını içeren, inflamatuvar bağırsak hastalığının tedavisine yönelik bir yöntemi sağlamaktadır. Mevcut buluş ayrıca yeni bakteriyofaj suşlarını sağlamaktadır.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305568.1A EP2799063A1 (en) | 2013-04-30 | 2013-04-30 | Bacteriophage therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201910955T4 true TR201910955T4 (tr) | 2019-08-21 |
Family
ID=48485088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/10955T TR201910955T4 (tr) | 2013-04-30 | 2014-04-30 | Bakteriyofaj terapisi. |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US11040078B2 (tr) |
| EP (3) | EP2799063A1 (tr) |
| JP (1) | JP6543615B2 (tr) |
| KR (1) | KR102215453B1 (tr) |
| CN (1) | CN105407872B (tr) |
| AU (1) | AU2014261461B2 (tr) |
| BR (1) | BR112015027269B1 (tr) |
| CA (1) | CA2910539C (tr) |
| DK (2) | DK2991633T3 (tr) |
| EA (1) | EA034195B1 (tr) |
| ES (2) | ES2902599T3 (tr) |
| HK (1) | HK1221164A1 (tr) |
| HR (2) | HRP20211860T2 (tr) |
| HU (2) | HUE044431T2 (tr) |
| IL (1) | IL242293B (tr) |
| LT (2) | LT3563837T (tr) |
| MX (1) | MX366497B (tr) |
| MY (1) | MY186607A (tr) |
| NZ (1) | NZ713423A (tr) |
| PH (1) | PH12015502500B1 (tr) |
| PL (2) | PL2991633T3 (tr) |
| PT (2) | PT2991633T (tr) |
| RS (2) | RS59046B1 (tr) |
| SA (1) | SA515370073B1 (tr) |
| SG (1) | SG11201508897QA (tr) |
| SI (2) | SI2991633T1 (tr) |
| TR (1) | TR201910955T4 (tr) |
| WO (1) | WO2014177622A1 (tr) |
| ZA (1) | ZA201508212B (tr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2799063A1 (en) | 2013-04-30 | 2014-11-05 | Ferring B.V. | Bacteriophage therapy |
| US20200078425A1 (en) * | 2017-03-14 | 2020-03-12 | Brigham Young University | Methods and Compositions for Treating Obesity, Inflammation, or Metabolic Disorders with Bacteriophages |
| AU2018330848A1 (en) * | 2017-09-08 | 2020-03-12 | Biomx Ltd. | Bacteriophage for modulating inflammatory bowel disease |
| CN112469426A (zh) * | 2018-05-23 | 2021-03-09 | 布莱阿姆青年大学 | 噬菌体组合物和试剂盒及相关方法 |
| US11986502B2 (en) | 2018-05-23 | 2024-05-21 | Optium, LLC | Bacteriophage compositions and kits and related methods |
| KR20220119470A (ko) * | 2019-12-23 | 2022-08-29 | 엔타시스 테라퓨틱스, 인크. | 미생물 장내불균형 관리 |
| US20220323518A1 (en) * | 2021-04-10 | 2022-10-13 | Intron Biotechnology, Inc. | Compositions and methods for inhibiting the proliferation of enterotoxigenic bacteroides fragilis |
| US20220331381A1 (en) * | 2021-04-10 | 2022-10-20 | Intron Biotechnology, Inc. | Compositions and methods for inhibiting the proliferation of enterotoxigenic bacteroides fragilis |
| US20220323517A1 (en) * | 2021-04-10 | 2022-10-13 | Intron Biotechnology, Inc. | Compositions and methods for inhibiting the proliferation of enterotoxigenic bacteroides fragilis |
| KR20230173188A (ko) | 2021-04-22 | 2023-12-26 | 훼링 비.브이. | 부착-침습성 대장균에 대한 박테리오파지 치료법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020013270A1 (en) * | 2000-06-05 | 2002-01-31 | Bolte Ellen R. | Method for treating a mental disorder |
| GB0019721D0 (en) * | 2000-08-10 | 2000-09-27 | Regma Biotechnologies Ltd | Novel method |
| EP2377883A1 (en) * | 2010-04-15 | 2011-10-19 | Universite d'Auvergne Clermont I | Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease |
| BR112013006400B1 (pt) * | 2010-09-17 | 2023-03-21 | Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa | Composição farmacêutica e seu uso, métodos relacionados a uma infecção bacteriana |
| WO2013045863A1 (fr) * | 2011-09-29 | 2013-04-04 | Institut Pasteur | Detection de souches e.coli de serotype o104 |
| EP2799063A1 (en) | 2013-04-30 | 2014-11-05 | Ferring B.V. | Bacteriophage therapy |
-
2013
- 2013-04-30 EP EP13305568.1A patent/EP2799063A1/en not_active Withdrawn
-
2014
- 2014-04-30 RS RS20190924A patent/RS59046B1/sr unknown
- 2014-04-30 WO PCT/EP2014/058840 patent/WO2014177622A1/en active Application Filing
- 2014-04-30 AU AU2014261461A patent/AU2014261461B2/en active Active
- 2014-04-30 DK DK14724663.1T patent/DK2991633T3/da active
- 2014-04-30 EP EP19172749.4A patent/EP3563837B9/en active Active
- 2014-04-30 ES ES19172749T patent/ES2902599T3/es active Active
- 2014-04-30 CA CA2910539A patent/CA2910539C/en active Active
- 2014-04-30 EA EA201591979A patent/EA034195B1/ru not_active IP Right Cessation
- 2014-04-30 SI SI201431268T patent/SI2991633T1/sl unknown
- 2014-04-30 LT LTEP19172749.4T patent/LT3563837T/lt unknown
- 2014-04-30 BR BR112015027269-0A patent/BR112015027269B1/pt active IP Right Grant
- 2014-04-30 LT LTEP14724663.1T patent/LT2991633T/lt unknown
- 2014-04-30 SI SI201431905T patent/SI3563837T1/sl unknown
- 2014-04-30 CN CN201480037529.9A patent/CN105407872B/zh active Active
- 2014-04-30 PL PL14724663T patent/PL2991633T3/pl unknown
- 2014-04-30 SG SG11201508897QA patent/SG11201508897QA/en unknown
- 2014-04-30 PL PL19172749T patent/PL3563837T3/pl unknown
- 2014-04-30 TR TR2019/10955T patent/TR201910955T4/tr unknown
- 2014-04-30 KR KR1020157034105A patent/KR102215453B1/ko active IP Right Grant
- 2014-04-30 JP JP2016511060A patent/JP6543615B2/ja active Active
- 2014-04-30 PT PT14724663T patent/PT2991633T/pt unknown
- 2014-04-30 MY MYPI2015002656A patent/MY186607A/en unknown
- 2014-04-30 HU HUE14724663 patent/HUE044431T2/hu unknown
- 2014-04-30 MX MX2015015092A patent/MX366497B/es active IP Right Grant
- 2014-04-30 US US14/787,581 patent/US11040078B2/en active Active
- 2014-04-30 HU HUE19172749A patent/HUE056968T2/hu unknown
- 2014-04-30 RS RS20211339A patent/RS62644B9/sr unknown
- 2014-04-30 NZ NZ713423A patent/NZ713423A/en unknown
- 2014-04-30 EP EP14724663.1A patent/EP2991633B1/en active Active
- 2014-04-30 HR HRP20211860TT patent/HRP20211860T2/hr unknown
- 2014-04-30 ES ES14724663T patent/ES2740124T3/es active Active
- 2014-04-30 PT PT191727494T patent/PT3563837T/pt unknown
- 2014-04-30 DK DK19172749.4T patent/DK3563837T5/da active
-
2015
- 2015-10-27 IL IL242293A patent/IL242293B/en active IP Right Grant
- 2015-10-29 SA SA515370073A patent/SA515370073B1/ar unknown
- 2015-10-29 PH PH12015502500A patent/PH12015502500B1/en unknown
- 2015-11-06 ZA ZA2015/08212A patent/ZA201508212B/en unknown
-
2016
- 2016-08-05 HK HK16109337.5A patent/HK1221164A1/zh unknown
-
2019
- 2019-07-29 HR HRP20191363 patent/HRP20191363T1/hr unknown
-
2021
- 2021-06-21 US US17/353,337 patent/US11918613B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201910955T4 (tr) | Bakteriyofaj terapisi. | |
| EA201690206A1 (ru) | Терапевтически активные соединения и способы их применения | |
| EA201491330A1 (ru) | Терапевтически активные соединения и способы их использования | |
| EA201990043A1 (ru) | Антибактериальные соединения | |
| UA122324C2 (uk) | Терапевтично активні сполуки і способи їх застосування | |
| EA201490004A1 (ru) | Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей | |
| EA201590343A1 (ru) | Алкилпиримидиновые производные для лечения вирусных инфекций и дальнейших заболеваний | |
| EA201691844A1 (ru) | Фармацевтические композиции терапевтически активных соединений | |
| EA201270566A1 (ru) | Противомикробные соединения и способы их получения и применения | |
| EA201590667A1 (ru) | Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний | |
| EA201391536A1 (ru) | Противомикробные соединения и способы их получения и применения | |
| EA201270567A1 (ru) | Противомикробные соединения и способы их получения и применения | |
| EA201491500A1 (ru) | Способы лечения фиброза | |
| PH12015501341A1 (en) | Chlorin derivative useful in photodynamic therapy and diagnosis | |
| MX2016006975A (es) | Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias. | |
| RU2013122987A (ru) | Способ лечения комбинированного радиационно-термического поражения | |
| PH12015502128A1 (en) | Novel dosing regimens of celgosivir for the treatment of dengue | |
| TR201900665T4 (tr) | Diyabetik nefropatinin tedavi yöntemi. | |
| EA201390925A1 (ru) | Производные санглиферина и способы их получения | |
| EA201592242A1 (ru) | Производные пиридона для лечения вирусных инфекций и других заболеваний | |
| EA201590522A1 (ru) | Способы введения рифаксимина для снижения веса и лечения ожирения | |
| MX2020006075A (es) | Composiciones farmaceuticas de bendamustina. | |
| EA201790220A1 (ru) | Лечение симптомов, связанных с андроген-депривационной терапией | |
| RU2013127881A (ru) | Применение фармацевтической композиции на основе соли четвертичного фосфония и замещенного динитробензофуроксана для лечения пироплазмоза у собак и способ лечения | |
| EA201491629A1 (ru) | Способы лечения рака с использованием липоплатина |